GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Herantis Pharma PLC (OHEL:HRTIS) » Definitions » Dividend-Payout-to-FFO

Herantis Pharma (OHEL:HRTIS) Dividend-Payout-to-FFO


View and export this data going back to 2014. Start your Free Trial

What is Herantis Pharma Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.


Herantis Pharma Business Description

Traded in Other Exchanges
N/A
Address
Bertel Jungin Aukio 1, Espoo, FIN, 02600
Herantis Pharma PLC is a biotech company developing disease-modifying therapies for Parkinson's disease. The company's current development program focuses solely on HER-096, which is a peptidomimetic molecule designed to retain the biological activity of the neuroprotective CDNF protein.